Addex Therapeutics Ltd Cash Flow Reinvestment Rate

Latest as of December 2020: 0.14x

Addex Therapeutics Ltd cash flow reinvestment rate. Addex Therapeutics Ltd (ADXN) has a Cash Flow Reinvestment Rate of 0.14x as of December 2020, reinvesting $96.17K (capex $48.09K plus investments $-48.09K) from operating cash flow of $704.85K. Explore Addex Therapeutics Ltd (ADXN) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.14x

(Capex + Investments) / Operating CF

Total Reinvested

$96.17K

Capex + Investments

Operating Cash Flow

$704.85K

USD

Capital Expenditures

$48.09K

USD

Cash Flow Reinvestment Rate of Addex Therapeutics Ltd (2018–2018)

Cash flow reinvestment rate of Addex Therapeutics Ltd from 2018 to 2018. Historical reinvestment intensity for Addex Therapeutics Ltd across 1 annual periods. Explore ADXN capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Addex Therapeutics Ltd Cash Flow Reinvestment Rate by Year (2018–2018)

Addex Therapeutics Ltd cash flow reinvestment rate by year from 2018 to 2018. Year-by-year capital reinvestment analysis for Addex Therapeutics Ltd. For the full cash flow conversion analysis, see how efficiently does Addex Therapeutics Ltd generate cash.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2018	0.03x	$56.37K	$1.75 Million	$9.05K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow